报价延迟最少15分钟:2026/06/21 09:52 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.11 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.98/--
|
|
企业价值
43.21M
|
| 资产负债 |
|
每股账面净值
0.98
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
22.54M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions. |
